170 related articles for article (PubMed ID: 29349917)
1. Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Terbuch A; Posch F; Partl R; Zurl B; Bauernhofer T; Pichler M; Szkandera J; Hutterer GC; Pummer K; Kapp KS; Stöger H; Gerger A; Stotz M
Cancer Med; 2018 Feb; 7(2):508-514. PubMed ID: 29349917
[TBL] [Abstract][Full Text] [Related]
2. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Febrile Neutropenia in Children With Solid Tumors Treated With Cisplatin-based Chemotherapy.
Castelán-Martínez OD; Rodríguez-Islas F; Vargas-Neri JL; Palomo-Colli MA; López-Aguilar E; Clark P; Castañeda-Hernández G; Rivas-Ruiz R
J Pediatr Hematol Oncol; 2016 Apr; 38(3):191-6. PubMed ID: 26907640
[TBL] [Abstract][Full Text] [Related]
4. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
Kojima T; Kawai K; Tsuchiya K; Abe T; Shinohara N; Tanaka T; Masumori N; Yamada S; Arai Y; Narita S; Tsuchiya N; Habuchi T; Nishiyama H
Int J Urol; 2015 Oct; 22(10):923-7. PubMed ID: 26094715
[TBL] [Abstract][Full Text] [Related]
5. The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
Wheater MJ; Manners J; Nolan L; Simmonds PD; Hayes MC; Mead GM
BJU Int; 2011 Dec; 108(11):1794-9. PubMed ID: 21627751
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Kawai T; Tanaka Y;
Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review.
Lyman GH; Abella E; Pettengell R
Crit Rev Oncol Hematol; 2014 Jun; 90(3):190-9. PubMed ID: 24434034
[TBL] [Abstract][Full Text] [Related]
8. A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study.
Fizazi K; Delva R; Caty A; Chevreau C; Kerbrat P; Rolland F; Priou F; Geoffrois L; Rixe O; Beuzeboc P; Malhaire JP; Culine S; Aubelle MS; Laplanche A
Eur Urol; 2014 Feb; 65(2):381-6. PubMed ID: 24094847
[TBL] [Abstract][Full Text] [Related]
9. Secondary neoplasms following treatment of malignant germ cell tumors.
Bokemeyer C; Schmoll HJ
J Clin Oncol; 1993 Sep; 11(9):1703-9. PubMed ID: 8394879
[TBL] [Abstract][Full Text] [Related]
10. Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494).
Morrison VA; Weller EA; Habermann TM; Li S; Fisher RI; Cheson BD; Peterson BA
Leuk Lymphoma; 2017 Aug; 58(8):1814-1822. PubMed ID: 27967294
[TBL] [Abstract][Full Text] [Related]
11. Medical treatment of advanced testicular cancer.
Feldman DR; Bosl GJ; Sheinfeld J; Motzer RJ
JAMA; 2008 Feb; 299(6):672-84. PubMed ID: 18270356
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-Based Chemotherapy for Testicular Germ Cell Tumors: Complication Rates of Peripheral versus Central Venous Administration.
Worst T; Sautter L; John A; Weiss C; Häcker A; Heinzelbecker J
Urol Int; 2016; 96(2):177-82. PubMed ID: 26681435
[TBL] [Abstract][Full Text] [Related]
13. Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy.
Kopp RP; Chevinsky M; Bernstein M; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
Urology; 2017 May; 103():154-160. PubMed ID: 27816603
[TBL] [Abstract][Full Text] [Related]
14. The risk of febrile neutropenia and need for G-CSF primary prophylaxis with the docetaxel and cyclophosphamide regimen in early-stage breast cancer patients: a meta-analysis.
Do T; Medhekar R; Bhat R; Chen H; Niravath P; Trivedi MV
Breast Cancer Res Treat; 2015 Oct; 153(3):591-7. PubMed ID: 26337685
[TBL] [Abstract][Full Text] [Related]
15. Persistent organochlorine pesticides and risk of testicular germ cell tumors.
McGlynn KA; Quraishi SM; Graubard BI; Weber JP; Rubertone MV; Erickson RL
J Natl Cancer Inst; 2008 May; 100(9):663-71. PubMed ID: 18445826
[TBL] [Abstract][Full Text] [Related]
16. [Germ cell tumors of the testes: state of the art].
Fléchon A; Droz JP
Cancer Radiother; 2000; 4(1):27-31. PubMed ID: 10742806
[TBL] [Abstract][Full Text] [Related]
17. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
[TBL] [Abstract][Full Text] [Related]
18. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
[TBL] [Abstract][Full Text] [Related]
19. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G
J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748
[TBL] [Abstract][Full Text] [Related]
20. Neutropenic sepsis rates in patients receiving bleomycin, etoposide and cisplatin chemotherapy using olanzapine and reduced doses of dexamethasone compared to a standard antiemetic regimen.
Gjafa E; Ng K; Grunewald T; Galazi M; Skyllberg E; Wilson P; Alifrangis C; Shamash J
BJU Int; 2021 Feb; 127(2):205-211. PubMed ID: 32668505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]